Related Experiment Video

Updated: Aug 19, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

[Chlamydia pneumoniae infection in patients with advanced carotid atherosclerosis]

Michał Karyński1, Piotr Słowiński, Paweł Grzesiowski

  • 1Narodowy Instytut Zdrowia Publicznego, Warszawa. paolo@cls.edu.pl

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|February 5, 2005
PubMed

Insights

This study investigated Chlamydia pneumoniae infection in advanced atherosclerosis. Researchers found no evidence of C. pneumoniae DNA in patient samples, regardless of antibody presence, suggesting no direct link to atherosclerosis.

Area of Science:

  • Cardiovascular Science
  • Infectious Disease Epidemiology

Context:

  • Advanced atherosclerosis is a growing concern with suspected infectious links.
  • Chlamydia pneumoniae has been investigated as a potential contributor to atherogenesis.
  • A clear pathogenetic link between C. pneumoniae and atherosclerosis remains unconfirmed.

Purpose:

  • To investigate the presence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells and carotid endarterectomy samples.
  • To correlate C. pneumoniae DNA presence with specific antibody levels in patients with advanced atherosclerosis.

Summary:

  • Researchers analyzed 36 patients undergoing carotid endarterectomy for C. pneumoniae DNA using nested PCR.
  • Enzyme immunoassay (EIA) detected IgG, IgM, and IgA antibodies to C. pneumoniae in patient sera.
  • No C. pneumoniae DNA was detected in carotid samples or peripheral blood mononuclear cells, irrespective of serological status.

Impact:

  • This study found no correlation between C. pneumoniae infection markers and the presence of bacterial DNA in advanced atherosclerosis.
  • The findings do not support a direct pathogenetic role for Chlamydia pneumoniae in the studied atherosclerosis cohort.
  • Further research may be needed to explore potential indirect mechanisms or other infectious agents in atherogenesis.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: